|
1
|
Siegel RL, Miller KD and Jemal A: Cancer
statistics, 2018. CA Cancer J Clin. 68:7–30. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Howlader N, Noone A, Krapcho M, Miller D,
Bishop K and Altekruse S: SEER Cancer Statistics Review, 1975–2015.
National Cancer Institute; Bethesda, MD: 2015
|
|
3
|
Chaffer CL and Weinberg RA: A perspective
on cancer cell metastasis. Science. 331:1559–1564. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kanno S, Nosho K, Ishigami K, Yamamoto I,
Koide H, Kurihara H, Mitsuhashi K, Shitani M, Motoya M, Sasaki S,
et al: MicroRNA-196b is an independent prognostic biomarker in
patients with pancreatic cancer. Carcinogenesis. 38:425–431. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Lu M, Kong X, Wang H, Huang G, Ye C and He
Z: A novel microRNAs expression signature for hepatocellular
carcinoma diagnosis and prognosis. Oncotarget. 8:8775–8784. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Peng Z, Pan L, Niu Z, Li W, Dang X, Wan L,
Zhang R and Yang S: Identification of microRNAs as potential
biomarkers for lung adenocarcinoma using integrating genomics
analysis. Oncotarget. 8:64143–64156. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Ahmadinejad F, Mowla SJ, Honardoost MA,
Arjenaki MG, Moazeni-Bistgani M, Kheiri S and Teimori H: Lower
expression of miR-218 in human breast cancer is associated with
lymph node metastases, higher grades, and poorer prognosis. Tumour
Biol. 39:10104283176983622017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Sun G, Liu Y, Wang K and Xu Z: miR-506
regulates breast cancer cell metastasis by targeting IQGAP1. Int J
Oncol. 47:1963–1970. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Sun G, Sun L, Liu Y, Xing H and Wang K:
Her-2 expression regulated by downregulation of miR-9 and which
affects chemotherapeutic effect in breast cancer. Cancer Gene Ther.
24:194–202. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Yang Z, He M, Wang K, Sun G, Tang L and Xu
Z: Tumor suppressive microRNA-193b promotes breast cancer
progression via targeting DNAJC13 and RAB22A. Int J Clin Exp
Pathol. 7:7563–7570. 2014.
|
|
11
|
Delprato A and Lambright DG: Structural
basis for Rab GTPase activation by VPS9 domain exchange factors.
Nat Struct Mol Biol. 14:406–412. 2007. View
Article : Google Scholar : PubMed/NCBI
|
|
12
|
Antonyak MA, Wilson KF and Cerione RAR:
R(h)oads to microvesicles. Small GTPases. 3:219–224. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mesa R, Magadán J, Barbieri A, López C,
Stahl PD and Mayorga LS: Overexpression of Rab22a hampers the
transport between endosomes and the Golgi apparatus. Exp Cell Res.
304:339–353. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Weigert R, Yeung AC, Li J and Donaldson
JG: Rab22a regulates the recycling of membrane proteins
internalized independently of clathrin. Mol Biol Cell.
15:3758–3770. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kauppi M, Simonsen A, Bremnes B, Vieira A,
Callaghan J, Stenmark H and Olkkonen VM: The small GTPase Rab22
interacts with EEA1 and controls endosomal membrane trafficking. J
Cell Sci. 115:899–911. 2002.PubMed/NCBI
|
|
16
|
Johnson DL, Wayt J, Wilson JM and
Donaldson JG: Arf6 and Rab22 mediate T cell conjugate formation by
regulating clathrin-independent endosomal membrane trafficking. J
Cell Sci. 130:2405–2415. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Wang T, Gilkes DM, Takano N, Xiang L, Luo
W, Bishop CJ, Chaturvedi P, Green JJ and Semenza GL:
Hypoxia-inducible factors and RAB22A mediate formation of
microvesicles that stimulate breast cancer invasion and metastasis.
Proc Natl Acad Sci USA. 111:E3234–E3242. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ruivo CF, Adem B, Silva M and Melo SA: The
Biology of Cancer Exosomes: Insights and New Perspectives. Cancer
Res. 77:6480–6488. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(−ΔΔC(T)) method. Methods. 25:402–408. 2001. View Article : Google Scholar
|
|
20
|
Justus CR, Leffler N, Ruiz-Echevarria M
and Yang LV: In vitro cell migration and invasion assays. J Vis
Exp. Jun 1–2014.Epub ahead of print. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Györffy B, Lanczky A, Eklund AC, Denkert
C, Budczies J, Li Q and Szallasi Z: An online survival analysis
tool to rapidly assess the effect of 22,277 genes on breast cancer
prognosis using microarray data of 1,809 patients. Breast Cancer
Res Treat. 123:725–731. 2010. View Article : Google Scholar
|
|
22
|
Li X, Zhang Y, Shi Y, Dong G, Liang J, Han
Y, Wang X, Zhao Q, Ding J, Wu K, et al: MicroRNA-107, an oncogene
microRNA that regulates tumour invasion and metastasis by targeting
DICER1 in gastric cancer. J Cell Mol Med. 15:1887–1895. 2011.
View Article : Google Scholar
|
|
23
|
Li J, Kong F, Wu K, Song K, He J and Sun
W: miR-193b directly targets STMN1 and uPA genes and suppresses
tumor growth and metastasis in pancreatic cancer. Mol Med Rep.
10:2613–2620. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Nyhan MJ, O’Donovan TR, Boersma AW, Wiemer
EA and McKenna SL: MiR-193b promotes autophagy and non-apoptotic
cell death in oesophageal cancer cells. BMC Cancer. 16:1012016.
View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Nakano H, Yamada Y, Miyazawa T and Yoshida
T: Gain-of-function microRNA screens identify miR-193a regulating
proliferation and apoptosis in epithelial ovarian cancer cells. Int
J Oncol. 42:1875–1882. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jin X, Sun Y, Yang H, Li J, Yu S, Chang X,
Lu Z and Chen J: Deregulation of the MiR-193b-KRAS Axis Contributes
to Impaired Cell Growth in Pancreatic Cancer. PLoS One.
10:e01255152015. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Kaukoniemi KM, Rauhala HE, Scaravilli M,
Latonen L, Annala M, Vessella RL, Nykter M, Tammela TL and
Visakorpi T: Epigenetically altered miR-193b targets cyclin D1 in
prostate cancer. Cancer Med. 4:1417–1425. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Moore C, Parrish JK and Jedlicka P:
MiR-193b, downregulated in Ewing Sarcoma, targets the ErbB4
oncogene to inhibit anchorage-independent growth. PLoS One.
12:e01780282017. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Su F, Chen Y, Zhu S, Li F, Zhao S, Wu L,
Chen X and Su J: RAB22A overexpression promotes the tumor growth of
melanoma. Oncotarget. 7:71744–71753. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Zhang B, Yin Y, Hu Y, Zhang J, Bian Z,
Song M, Hua D and Huang Z: MicroRNA-204-5p inhibits gastric cancer
cell proliferation by downregulating USP47 and RAB22A. Med Oncol.
32:3312015. View Article : Google Scholar
|
|
31
|
Yin Y, Zhang B, Wang W, Fei B, Quan C,
Zhang J, Song M, Bian Z, Wang Q, Ni S, et al: miR-204-5p inhibits
proliferation and invasion and enhances chemotherapeutic
sensitivity of colorectal cancer cells by downregulating RAB22A.
Clin Cancer Res. 20:6187–6199. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Maia J, Caja S, Strano Moraes MC, Couto N
and Costa-Silva B: Exosome-based cell-cell communication in the
tumor microen-vironment. Front Cell Dev Biol. 6:182018. View Article : Google Scholar
|
|
33
|
Yáñez-Mó M, Siljander PR, Andreu Z, Zavec
AB, Borràs FE, Buzas EI, Buzas K, Casal E, Cappello F, Carvalho J,
et al: Biological properties of extracellular vesicles and their
physiological functions. J Extracell Vesicles. 4:270662015.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Kishore R and Khan M: More than tiny
sacks: Stem cell exosomes as cell-free modality for cardiac repair.
Circ Res. 118:330–343. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Yu DD, Wu Y, Shen HY, Lv MM, Chen WX,
Zhang XH, Zhong SL, Tang JH and Zhao JH: Exosomes in development,
metastasis and drug resistance of breast cancer. Cancer Sci.
106:959–964. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Lowry MC, Gallagher WM and O’Driscoll L:
The Role of Exosomes in Breast Cancer. Clin Chem. 61:1457–1465.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Rivoltini L, Chiodoni C, Squarcina P,
Tortoreto M, Villa A, Vergani B, Bürdek M, Botti L, Arioli I, Cova
A, et al: TNF-related apoptosis-inducing ligand (TRAIL)-armed
exosomes deliver proapoptotic signals to tumor site. Clin Cancer
Res. 22:3499–3512. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Boelens MC, Wu TJ, Nabet BY, Xu B, Qiu Y,
Yoon T, Azzam DJ, Twyman-Saint Victor C, Wiemann BZ, Ishwaran H, et
al: Exosome transfer from stromal to breast cancer cells regulates
therapy resistance pathways. Cell. 159:499–513. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Riches A, Campbell E, Borger E and Powis
S: Regulation of exosome release from mammary epithelial and breast
cancer cells - a new regulatory pathway. Eur J Cancer.
50:1025–1034. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Languino LR, Singh A, Prisco M, Inman GJ,
Luginbuhl A, Curry JM and South AP: Exosome-mediated transfer from
the tumor microenvironment increases TGFβ signaling in squamous
cell carcinoma. Am J Transl Res. 8:2432–2437. 2016.
|
